Nutex Health (US:NUTX) Prnewswire·2025-09-29 12:45Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, which has led to a class action lawsuit against the company [1]. Group 1: Allegations and Issues - The complaint alleges that Nutex Health's third-party vendor, HaloMD, engaged in fraudulent activities to achieve favorable arbitration results, which inflated the company's revenues [1]. - It is claimed that the revenues from HaloMD's engagement in the IDR process were unsustainable due to the fraudulent nature of the conduct [1]. - The company allegedly overstated its ability to remediate material weaknesses in its internal controls over financial reporting, leading to improper accounting of stock-based compensation obligations [1]. - Nutex is accused of misclassifying stock-based compensation obligations as equity instead of liabilities, increasing the risk of delays in filing financial reports with the SEC [1]. - The allegations suggest that Nutex's business and financial prospects were overstated, making the public statements by the defendants materially false and misleading [1]. Group 2: Class Action Details - Shareholders who purchased shares of Nutex Health during the specified class period are encouraged to register for the class action lawsuit, with a deadline for lead plaintiff appointment set for October 21, 2025 [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. - Participation in the case does not incur any cost or obligation for the shareholders [2].